Marcin Chwistek, MD, FAAHPM

Marcin Chwistek, MD, FAAHPM

Request an Appointment

Call 888-369-2427

Request Online

Clinical Locations

  • Fox Chase Cancer Center
    333 Cottman Avenue
    Philadelphia, PA 19111
    Phone: 888-369-2427

Professor, College of Public Health, Temple University

Director, Supportive Oncology and Palliative Care Program

Professor, Department of Hematology/Oncology

Associate Editor, Journal of Pain and Symptom Management

Physician Leader, Schwartz Center Rounds

NCCN, Adult Cancer Pain Panel Member

Specialties

  • Hospice and Palliative Care

Treatment Focus

  • Palliative Care; Cancer Pain Management
  • Supportive Oncology, Cancer Pain Management, Palliative Care

Research Program

Distinctions

Treatment Philosophy

As a palliative care physician, it is my true privilege to care for individuals with cancer. Palliative care is an interdisciplinary specialty that focuses on supporting the best possible quality of life for patients and their families facing serious illness.

In my clinical work, I seek to ease patients’ distress by focusing on relieving pain and other emotional and physical symptoms. Cancer care today is very complex, and deciding on the right treatment choices can be challenging. Helping individuals make health care decisions that are most congruent with their personal values, needs, beliefs and preferences is a crucial part of my work. Our team works very closely with each patient, family and the primary oncology team to provide care that is efficient and well-coordinated.

I feel very fortunate to practice at Fox Chase Cancer Center, which has enjoyed a long tradition of providing high-quality palliative care to its patients. I am truly proud to lead a team of incredibly dedicated and highly skilled clinicians who strive daily to improve the quality of life for individuals with cancer, their families and caregivers.

Follow on Twitter: @mchwistek

Educational Background

  • Fellow, Pain and Palliative Care, Memorial Sloan-Kettering Cancer Center, New York, NY
  • Fellow, Integrative Medicine, University of Arizona, Tuscon, AZ
  • Resident, Internal Medicine, Yale University-Bridgeport Hospital, Bridgeport, CT
  • MD, Jagiellonian University Medical College, Krakow, Poland, 1993

Certifications

  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine - Hospice and Palliative Medicine
  • American Board of Psychiatry and Neurology - Pain Management

Memberships

  • National Comprehensive Cancer Network (NCCN)
    • Adult Cancer Pain Panel
  • American Academy of Hospice and Palliative Medicine
  • International Association for the Study of Pain

Honors & Awards

  • Philadelphia Magazine Top Doctors, 2012-2024
  • America's Top Doctors®, 2016-17
  • Fox Chase Award, Exemplifying the Spirit of Survivorship, Fox Chase Cancer Center, 2013
  • Nominee, Longstreth Humaness Award, Bridgeport Hospital, 2000

Research Interests

Cancer Pain Management, Palliative Medicine; Cancer Survivorship; Patient-Physician Communication

Selected Publications

Risks associated with opioid use. Chwistek M. JAMA. 2013 Oct 23;310(16):1737. doi: 10.1001/jama.2013.277305. No abstract available. PMID: 24150475

 

Vertebroplasty and kyphoplasty for vertebral compression fractures #202. Chwistek M, Mehta RS. J Palliat Med. 2012 Oct;15(10):1151-2. doi: 10.1089/jpm.2012.9556. No abstract available. PMID: 22957679

 

Books: When you have eliminated the impossible …CMAJ October 16, 2012 184:E823; published ahead of print July 3, 2012, doi:10.1503/cmaj.111452

 

Management of chronic pain in cancer survivors. Levy MH, Chwistek M, Mehta RS. Cancer J. 2008 Nov- Dec;14(6):401-9. doi: 10.1097/PPO.0b013e31818f5aa7. Review. PMID: 19060605

 

Bisphosphonates and osteonecrosis of the jaw #196. Mehta RS, Chwistek M. J Palliat Med. 2008 Sep;11(7):1039-40. doi: 10.1089/jpm.2008.9866. No abstract available. PMID: 18788967

 

Gallstone pancreatitis: a community teaching hospital experience. Chwistek M, Roberts I, Amoateng-Adjepong Y. J Clin Gastroenterol. 2001 Jul;33(1):41-4. PMID: 11418789

 

Chwistek M. Mitigating the Risk of Aberrant Use of Opioids in Patients With Cancer Pain. J Natl Compr Canc Netw. 2023 Nov;21(11):1212-1213. doi: 10.6004/jnccn.2023.7095. PMID: 37935107. 

 

Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, Chwistek M, Cleeland C, Craig D, Gafford E, Greenlee H, Hansen E, Kamal AH, Kamdar MM, LeGrand S, Mackey S, McDowell MR, Moryl N, Nabell LM, Nesbit S; BCPS; O'Connor N, Rabow MW, Rickerson E, Shatsky R, Sindt J, Urba SG, Youngwerth JM, Hammond LJ, Gurski LA. Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 Aug 1;17(8):977-1007. doi: 10.6004/jnccn.2019.0038. PMID: 31390582. 

 

Chwistek M, Sherry D, Kinczewski L, Silveira MJ, Davis M. Should Buprenorphine Be Considered a First-Line Opioid for the Treatment of Moderate to Severe Cancer Pain? J Pain Symptom Manage. 2023 Nov;66(5):e638-e643. doi: 10.1016/j.jpainsymman.2023.06.022. Epub 2023 Jun 19. PMID: 37343903. 

 

Chwistek M, Sherry D, Kinczewski L, Silveira MJ, Davis M. Should Buprenorphine Be Considered a First-Line Opioid for the Treatment of Moderate to Severe Cancer Pain? J Pain Symptom Manage. 2023 Nov;66(5):e638-e643. doi: 10.1016/j.jpainsymman.2023.06.022. Epub 2023 Jun 19. PMID: 37343903. 

 

Chwistek M, Sherry D, Kinczewski L, Silveira MJ, Davis M. Should Buprenorphine Be Considered a First-Line Opioid for the Treatment of Moderate to Severe Cancer Pain? J Pain Symptom Manage. 2023 Nov;66(5):e638-e643. doi: 10.1016/j.jpainsymman.2023.06.022. Epub 2023 Jun 19. PMID: 37343903. 

Additional Publications

My NCBI

Resize Text

Related Articles

00 / 00